|
Eine Ebene nach oben |
Gruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 24
Zeitschriftenartikel
Guenther, Michael; Surendran, Sai Agash; Haas, Michael; Heinemann, Volker; Bergwelt-Baildon, Michael von 
ORCID: https://orcid.org/0000-0002-1952-052X; Engel, Jutta; Werner, Jens; Boeck, Stefan ORCID: https://orcid.org/0000-0002-1922-2127 und Ormanns, Steffen ORCID: https://orcid.org/0000-0002-0754-9034
(2023):
TPX2 expression as a negative predictor of gemcitabine efficacy in pancreatic cancer.
In: British Journal of Cancer, Bd. 129: S. 175-182
[PDF, 1MB]
ORCID: https://orcid.org/0000-0002-1952-052X; Engel, Jutta; Werner, Jens; Boeck, Stefan ORCID: https://orcid.org/0000-0002-1922-2127 und Ormanns, Steffen ORCID: https://orcid.org/0000-0002-0754-9034
(2023):
TPX2 expression as a negative predictor of gemcitabine efficacy in pancreatic cancer.
In: British Journal of Cancer, Bd. 129: S. 175-182
[PDF, 1MB]
Randeu, Hannah; Bronkhorst, Abel J.; Mayer, Zsuzsanna; Oberhofer, Angela; Polatoglou, Eleni; Heinemann, Volker; Haas, Michael; Böck, Stefan und Holdenrieder, Stefan
(2022):
Preanalytical Variables in the Analysis of Mitochondrial DNA in Whole Blood and Plasma from Pancreatic Cancer Patients.
In: Diagnostics, Bd. 12, Nr. 8, 1905
Zhang, Danmei; Kruger, Stephan; Schirle, Karoline; Heinemann, Volker; Dorman, Klara; Westphalen, Benedikt; Weiss, Lena; Gebauer, Leonie; Gunther, Michael; Ormanns, Steffen; Werner, Jens; Bergwelt-Baildon, Michael von; Boeck, Stefan und Haas, Michael
(2022):
Clinical impact of structured post-operative surveillance in resected pancreatic adenocarcinoma: Results from a retrospective cohort study.
In: Oncology Research and Treatment, Bd. 46, Nr. 3: S. 106-115
Dorman, Klara; Gerckens, Miriam; Kruger, Stephan; Krueger, Kimberly; Mayer, Zsuzsanna; Rupp, Alexander; Zhang, Danmei; Weiss, Lena; Westphalen, C. Benedikt; Haas, Michael; Guenther, Michael; Ormanns, Steffen; Klawonn, Frank; Werner, Jens; Bergwelt-Baildon, Michael von; Heinemann, Volker; Böck, Stefan und Holdenrieder, Stefan
(2022):
Serum biomarker panel diagnostics in pancreatic ductal adenocarcinoma: the clinical utility of soluble interleukins, IFN-gamma, TNF-alpha and PD-1/PD-L1 in comparison to established serum tumor markers.
In: Journal of Cancer Research and Clinical Oncology, Bd. 149, Nr. 6: S. 2463-2474
[PDF, 1MB]
Gebauer, Leonie; Moltz, Jan H.; Mühlberg, Alexander; Holch, Julian W.; Huber, Thomas; Enke, Johanna; Jäger, Nils; Haas, Michael; Kruger, Stephan; Boeck, Stefan; Sühling, Michael; Katzmann, Alexander; Hahn, Horst; Kunz, Wolfgang G.; Heinemann, Volker; Noerenberg, Dominik und Maurus, Stefan
(2021):
Quantitative Imaging Biomarkers of the Whole Liver Tumor Burden Improve Survival Prediction in Metastatic Pancreatic Cancer.
In: Cancers, Bd. 13, Nr. 22, 5732
Schulz, Christoph; Heinemann, Volker; Heinrich, Kathrin; Haas, Michael; Holch, Julian W.; Fraccaroli, Alessia; Held, Swantje; Einem, Jobst C.von; Modest, Dominik P.; Fischer von Weikersthal, Ludwig; Kullmann, Frank; Moehler, Markus; Scheithauer, Werner; Jung, Andreas und Stintzing, Sebastian
(2020):
Predictive and prognostic value of magnesium serum level in FOLFIRI plus cetuximab or bevacizumab treated patients with stage IV colorectal cancer: results from the FIRE-3 (AIO KRK-0306) study.
In: Anti-Cancer Drugs, Bd. 31, Nr. 8: S. 856-865
Guenther, Michael; Haas, Michael; Heinemann, Volker; Kruger, Stephan; Westphalen, Christoph Benedikt; Bergwelt-Baildon, Michael von; Mayerle, Julia; Werner, Jens; Kirchner, Thomas; Boeck, Stefan und Ormanns, Steffen
(2020):
Bacterial lipopolysaccharide as negative predictor of gemcitabine efficacy in advanced pancreatic cancer - translational results from the AIO-PK0104 Phase 3 study.
In: British Journal of Cancer, Bd. 123, Nr. 9: S. 1370-1376
Kruger, Stephan; Schirle, Karoline; Haas, Michael; Crispin, Alexander; Schirra, Jörg; Mayerle, Julia; D'Haese, Jan G.; Kunz, Wolfgang G.; Ricke, Jens; Ormanns, Steffen; Kirchner, Thomas; Kobold, Sebastian; Ilmer, Matthias; Gebauer, Leonie; Westphalen, Christoph B.; Bergwelt-Baildon, Michael von; Werner, Jens; Heinemann, Volker und Boeck, Stefan
(2020):
Prolonged time to treatment initiation in advanced pancreatic cancer patients has no major effect on treatment outcome: a retrospective cohort study controlled for lead time bias and waiting time paradox.
In: Journal of Cancer Research and Clinical Oncology, Bd. 146, Nr. 2: S. 391-399
Günther, Michael; Veninga, Vivien; Kumbrink, Jörg; Haas, Michael; Westphalen, C. Benedikt; Kruger, Stephan; Heinemann, Volker; Kirchner, Thomas; Böck, Stefan; Jung, Andreas und Ormanns, Steffen
(2018):
POLE gene hotspot mutations in advanced pancreatic cancer.
In: Journal of Cancer Research and Clinical Oncology, Bd. 144, Nr. 11: S. 2161-2166
Laethem, Jean-Luc Van; Riess, Hanno; Jassem, Jacek; Haas, Michael; Martens, Uwe M.; Weekes, Colin; Peeters, Marc; Ross, Paul; Bridgewater, John; Melichar, Bohuslav; Cascinu, Stefano; Saramak, Piotr; Michl, Patrick; Brummelen, David Van; Zaniboni, Alberto; Schmiegel, Wollf; Dueland, Svein; Giurescu, Marius; Garosi, Vittorio L.; Roth, Katrin; Schulz, Anke; Seidel, Henrik; Rajagopalan, Prabhu; Teufel, Michael und Childs, Barrett H.
(2017):
Phase I/II Study of Refametinib (BAY 86-9766) in Combination with Gemcitabine in Advanced Pancreatic cancer.
In: Targeted Oncology, Bd. 12, Nr. 1: S. 97-109
Kruger, Stephan; Legenstein, Marie-Louise; Rösgen, Verena; Haas, Michael; Modest, Dominik Paul; Westphalen, Christoph Benedikt; Ormanns, Steffen; Kirchner, Thomas; Heinemann, Volker; Holdenrieder, Stefan und Boeck, Stefan
(2017):
Serum levels of soluble programmed death protein 1 (sPD-1) and soluble programmed death ligand 1 (sPD-L1) in advanced pancreatic cancer.
In: Oncoimmunology, Bd. 6, Nr. 5, e1310358
Ormanns, Steffen; Haas, Michael; Remold, Anna; Kruger, Stephan; Holdenrieder, Stefan; Kirchner, Thomas; Heinemann, Volker und Boeck, Stefan
(2017):
The Impact of SMAD4 Loss on Outcome in Patients with Advanced Pancreatic Cancer Treated with Systemic Chemotherapy.
In: International Journal of Molecular Sciences, Bd. 18, Nr. 5, 1094
[PDF, 1MB]
Haas, Michael; Ormanns, Steffen; Bächmann, Sibylle; Remold, Anna; Krüger, Stephan; Westphalen, Christoph B.; Siveke, Jens T.; Wenzel, Patrick; Schlitter, Anna Melissa; Esposito, Irene; Quietzsch, Detlef; Clemens, Michael R.; Kettner, Erika; Laubender, Rüdiger P.; Jung, Andreas; Kirchner, Thomas; Böck, Stefan und Heinemann, Volker
(2017):
Extended RAS analysis and correlation with overall survival in advanced pancreatic cancer.
In: British Journal of Cancer, Bd. 116, Nr. 11: S. 1462-1469
Bächmann, Sibylle; Ormanns, Steffen; Haas, Michael; Krüger, Stephan; Remold, Anna; Modest, Dominik Paul; Kirchner, Thomas; Jung, Andreas; Werner, Jens; Heinemann, Volker und Böck, Stefan
(2017):
Switch in KRAS mutational status during an unusual course of disease in a patient with advanced pancreatic adenocarcinoma: implications for translational research.
In: BMC Cancer
17:374
[PDF, 614kB]
Kruger, Stephan; Haas, Michael; Burkl, Carolin; Goehring, Peter; Kleespies, Axel; Röder, Falk; Gallmeier, Eike; Ormanns, Steffen; Westphalen, Christoph Benedikt; Heinemann, Volker; Rank, Andreas und Boeck, Stefan
(2017):
Incidence, outcome and risk stratification tools for venous thromboembolism in advanced pancreatic cancer - A retrospective cohort study.
In: Thrombosis Research, Bd. 157: S. 9-15
Stahler, Arndt; Heinemann, Volker; Neumann, Jens; Crispin, Alexander; Schalhorn, Andreas; Stintzing, Sebastian; Giessen-Jung, Clemens; Fischer von Weikersthal, Ludwig; Vehling-Kaiser, Ursula; Stauch, Martina; Quietzsch, Detlef; Holch, Julian W.; Kruger, Stephan; Haas, Michael; Michl, Marlies; Einem, Jobst von; Kirchner, Thomas; Jung, Andreas und Modest, Dominik P.
(2017):
Prevalence and influence on outcome of HER2/neu, HER3 and NRG1 expression in patients with metastatic colorectal cancer.
In: Anti-cancer drugs, Bd. 28, Nr. 7: S. 717-722
[PDF, 422kB]
Westphalen, C. Benedikt; Kruger, Stephan; Haas, Michael; Heinemann, Volker und Boeck, Stefan
(2016):
Safety of palliative chemotherapy in advanced pancreatic cancer.
In: Expert Opinion On Drug Safety, Bd. 15, Nr. 7: S. 947-954
Ormanns, Steffen; Haas, Michael; Baechmann, Sibylle; Altendorf-Hofmann, Annelore; Remold, Anna; Quietzsch, Detlef; Clemens, Michael R.; Bentz, Martin; Geissler, Michael; Lambertz, Helmut; Kruger, Stephan; Kirchner, Thomas; Heinemann, Volker und Boeck, Stefan
(2016):
Impact of SPARC expression on outcome in patients with advanced pancreatic cancer not receiving nab-paclitaxel: a pooled analysis from prospective clinical and translational trials.
In: British Journal of Cancer, Bd. 115, Nr. 12: S. 1520-1529
Kruger, Stephan; Haas, Michael; Burger, Philipp Johannes; Ormanns, Steffen; Modest, Dominik Paul; Westphalen, Christoph Benedikt; Kleespies, Axel; Angele, Martin Kurt; Hartwig, Werner; Bruns, Christiane Josephine; Kirchner, Thomas; Werner, Jens; Heinemann, Volker und Boeck, Stefan
(2016):
Acinar cell carcinoma of the pancreas: a rare disease with different diagnostic and therapeutic implications than ductal adenocarcinoma.
In: Journal of Cancer Research and Clinical Oncology, Bd. 142, Nr. 12: S. 2585-2591
Kruger, Stephan; Haas, Michael; Burger, Philipp Johannes; Ormanns, Steffen; Modest, Dominik Paul; Westphalen, Christoph Benedikt; Michl, Marlies; Kleespies, Axel; Angele, Martin Kurt; Hartwig, Werner; Bruns, Christiane Josephine; Niyazi, Maximilian; Roeder, Falk; Kirchner, Thomas; Werner, Jens; Heinemann, Volker und Boeck, Stefan
(2016):
Isolated pulmonary metastases define a favorable subgroup in metastatic pancreatic cancer.
In: Pancreatology, Bd. 16, Nr. 4: S. 593-598
Kruger, Stephan; Angele, Martin K.; Reu, Simone; Sotlar, Karl; Graser, Anno; Haas, Michael; Albertsmeier, Markus; Stemmler, Hans-Joachim; Heinemann, Volker; Lindner, Lars H. und Böck, Stefan
(2014):
Complete pathological response to neoadjuvant pemetrexed/cisplatin in combination with regional hyperthermia in a patient with sarcomatoid peritoneal mesothelioma.
In: Anti-Cancer Drugs, Bd. 25, Nr. 7: S. 854-856
[PDF, 248kB]
Ormanns, Steffen; Siveke, Jens T.; Heinemann, Volker; Haas, Michael; Sipos, Bence; Schlitter, Anna Melissa; Esposito, Irene; Jung, Andreas; Laubender, Rüdiger P.; Kruger, Stephan; Vehling-Kaiser, Ursula; Winkelmann, Cornelia; Fischer von Weikersthal, Ludwig; Clemens, Michael R.; Gauler, Thomas C.; Märten, Angela; Geissler, Michael; Greten, Tim F.; Kirchner, Thomas und Boeck, Stefan
(2014):
pERK, pAKT and p53 as tissue biomarkers in erlotinib-treated patients with advanced pancreatic cancer: a translational subgroup analysis from AIO-PK0104.
In: BMC Cancer
14:624
[PDF, 408kB]
Stintzing, Sebastian; Fischhaber, Doris; Mook, Charlotte; Modest, Dominik P.; Giessen, Clemens; Schulz, Christoph; Haas, Michael; Böck, Stefan; Michl, Marlies; Stemmler, Joachim; Laubender, Ruediger P. und Heinemann, Volker
(Oktober 2013):
Clinical relevance and utility of cetuximab-related changes in magnesium and calcium serum levels.
In: Anti-Cancer Drugs, Bd. 24, Nr. 9: S. 969-974
[PDF, 372kB]
Boeck, Stefan; Wilkowski, Ralf; Bruns, Christiane J.; Issels, Rolf-Dieter; Schulz, Christoph; Moosmann, Nicolas; Laessig, Dorit; Haas, Michael; Golf, Alexander und Heinemann, Volker
(2007):
Oral capecitabine in gemcitabine-pretreated patients with advanced pancreatic cancer.
In: Oncology, Nr. 3-4: S. 221-227
[PDF, 330kB]